CLC Number:
| [1] Tan A, Ralston SH. Pagets disease of bone[J]. QJM, 2014, 107(11): 865-869. [2] Patil AK, Muthusamy K, Aaron S, et al. A case of Erdheim Chester disease with central nervous system involvement[J]. Ann Indian Acad Neurol, 2015, 18(3): 338-341. [3] Maatallah K, Ben Nessib D, Labbène E, et al. Pagets disease of bone in patients under 40 years: two case reports and review of the literature[J]. Sultan Qaboos Univ Med J, 2021, 21(1): e127-e131. [4] Wani S, Daroszewska A, Salter DM, et al. The Pagets disease of bone risk gene PML is a negative regulator of osteoclast differentiation and bone resorption[J]. Dis Model Mech, 2022, 15(4): dmm049318. [5] Gennari L, Rendina D, Merlotti D, et al. Update on the pathogenesis and genetics of Pagets disease of bone[J]. Front Cell Dev Biol, 2022, 10: 932065. doi:10.3389/fcell.2022.932065. [6] Cundy T. Pagets disease of bone[J]. Metabolism, 2018, 80: 5-14. doi: 10.1016/j.metabol.2017.06.010. [7] Cundy T, Maslowski K, Grey A, et al. Durability of response to zoledronate treatment and competing mortality in Pagets disease of bone[J]. J Bone Miner Res, 2017, 32(4): 753-756. [8] Mazor RD, Manevich-Mazor M, Shoenfeld Y. Erdheim-chester disease: a comprehensive review of the literature[J]. Orphanet J Rare Dis, 2013, 8: 137-149. doi: 10.1186/1750-1172-8-137. [9] Haroche J, Cohen-Aubart F, Amoura Z. Erdheim-chester disease[J]. Blood, 2020, 135(16): 1311-1318. [10] Papo M, Emile JF, Maciel TT, et al. Erdheim-chester disease: a concise review[J]. Curr Rheumatol Rep, 2019, 21(12): 66. [11] Goyal G, Heaney ML, Collin M, et al. Erdheim-Chester disease: consensus recommendations for evaluation, diagnosis, and treatment in the molecular era[J]. Blood, 2020, 135(22): 1929-1945. [12] Pan ZG, Kleinschmidt-DeMasters BK. CNS erdheim-chester disease: a challenge to diagnose[J]. J Neuropathol Exp Neurol, 2017, 76(12): 986-996. [13] Cives M, Simone V, Rizzo FM, et al. Erdheim-Chester disease: a systematic review[J]. Crit Rev Oncol Hematol, 2015, 95(1): 1-11. [14] Shekhar S, Irizarry-Caro JA, Sinaii N, et al. Pituitary imaging abnormalities and related endocrine disorders in erdheim-chester disease[J]. Cancers(Basel), 2021, 13(16): 4126. [15] Emile JF, Abla O, Fraitag S, et al. Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages[J]. Blood, 2016, 127(22): 2672-2681. [16] Nordmann TM, Juengling FD, Recher M, et al. Trametinib after disease reactivation under dabrafenib in Erdheim-Chester disease with both BRAF and KRAS mutations[J]. Blood, 2017, 129(7): 879-882. |
| [1] | . [J]. Journal of Shandong University (Health Sciences), 2022, 60(3): 117-120. |
| [2] | ZHOU Lanlan, PAN Xueyi, GUO Yu. Clinical characteristics and prognosis of 48 patients with mixed phenotype acute leukemia [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(2): 79-83. |
| [3] | HAN Kangkang, CUI Liwei, PENG Cheng, XUE Yuwen, XIAO Wei. Multiple serous effusion complicated with Warburg effect: a case report of diffuse large B-cell lymphoma and literature review [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(7): 80-87. |
| [4] | YANG Juan, QIU Zongjian, SONG Qiang. Impacts of Simvastatin on DNA methyltransferase of cell line NB4 in acute myeloid leukemia [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(6): 28-32. |
| [5] | . [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(S2): 46-47. |
| [6] | . [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(10): 111-112. |
| [7] | QIU Zongjian, YANG Juan, SONG Qiang. Role of decitabine in the mitochondria biogenesis of synchronized G0/G1 phase MDS-L cell line [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(5): 5-9. |
| [8] | . [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(2): 109-112. |
| [9] | LIU Lu, LIU Chuan-fang, WANG Min, TIAN Tian, YU Shuang, HE Na, SUN Yuan-xin, MA Dao-xin. The aberrant expression of microRNA-181a, microRNA-146a, microRNA-326 and microRNA-142-3p in peripheral blood of patients with immune thrombocytopenia [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(12): 55-60. |
| [10] | ZHAI Shan-shan1, DING Bu-tong2, LI Hai-xia3, CHEN Yun1, CHANG Ya-li1, SANG Tan1, GUO Nong-jian1. Differential expressions of microRNAs in the CD138+ cells of multiple myeloma patients with deletion of chromosome 13 [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(5): 80-84. |
| [11] | SUN Yuan-xin1, QIN Xue-mei1, LIU Xi-min2, WANG Li-zhi2, LIU Chuan-fang1, LIU Lu1. Relationship between regulatory T cells, IL-35 and aGVHD after allo-HSCT [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(3): 89-94. |
| [12] | XU Jia, SONG Qiang. Deletion of the RASSF1A gene and promoter methylation in the bone marrow of patients with myelodysplastic syndromes [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(2): 65-69. |
| [13] |
YIN Dong-mei1, XU Hong-zhi1, ZHANG Jing-yao1, SUI Xiao-hui1, CUI Bin2, MA Chun-yan2, ZHEN Chang-qing1.
Changes and clinical significances of CD4+T cell subsets in aplastic anemia, myelodysplastic syndromes and acute myeloid leukemia patients [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(3): 66-70. |
| [14] |
SANG Tan1, DING Bu-tong2, CHANG Ya-li1, CHEN Yun1, LI Zhi-hong2,WANG Yun-shan2， HAN Shu-yi2, TONG Shu-qing2, GUO Nong-jian1 .
ETV6 gene rearrangements in adult acute lymphoblastic leukemia and their clinical significance [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(3): 79-82. |
| [15] | GUO Xiao-ling1， ZHANG Gai-ling1， YIN Feng-lei1， NIU Zhi-yun1， ZHANG Xue-jun1， DONG Zuo-ren1， ZHU Ping2， PAN Ling1. Detection of the Mxi1 gene mutation and construction of the expression vector in the leukemia cell line KG-1 [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(10): 89-. |
|
||
